A detailed history of Lynwood Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Lynwood Capital Management Inc. holds 1,502 shares of PFE stock, worth $39,592. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,502
Holding current value
$39,592
% of portfolio
0.37%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $38,886 - $44,654
1,502 New
1,502 $41,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $1.81 Million - $2.09 Million
50,000 New
50,000 $1.83 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lynwood Capital Management Inc. Portfolio

Follow Lynwood Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynwood Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynwood Capital Management Inc. with notifications on news.